Kanye West and Irina Shayk are v. much still dating, and a source tells Us Weekly that they’re in the ~honeymoon phase~ of their relationship. To quote: “Kanye and Irina are in a honeymoon, lovey-dovey phase right now. They’re getting to know each other and having a lot of fun. It’s not serious yet, but… Read More »
Dr. Deborah L. Birx, the Trump administration’s coronavirus coordinator, said on Sunday that the nation was in a “new phase” of the coronavirus epidemic that was much more sprawling across the country than last spring’s outbreaks in major cities like New York and Seattle. She recommended that people living in communities where cases are surging… Read More »
Novo Nordisk has long been working on drugs that can help people earlier on in their diabetes and keep them from progressing to insulin treatment. But that doesn’t mean it’s not also working to improve the insulin options out there for those who do need it. Sunday at the American Diabetes Association’s virtual annual meeting,… Read More »
Media playback is unsupported on your device UK health officials are moving towards the second phase of their response to the coronavirus outbreak. In the “delay” phase measures will be ramped up to slow the spread of the virus, the country’s chief medical adviser Prof Chris Whitty said. He told MPs it was “highly likely”… Read More »
In a major victory that could signal the beginning of the end for the use of glyphosate as a preharvest drying agent, or desiccant, food giant Kellogg has announced they’re phasing out the practice. In a quiet revelation on their website’s glyphosate Q&A page, Kellogg addressed a question they’ve had from customers, which asks, “I’ve… Read More »
The J.P. Morgan Healthcare Conference may be over, but that doesn’t mean the dealmaking is. Often, deals that took shape at the meeting materialize later in the year, and some recent buzz puts Pfizer and Biogen at the center of potential takeovers. Pfizer is reportedly eyeing a buyout of cardiovascular player Amarin, whose fish-oil-derived lipid drug… Read More »
The year may be winding down, but AstraZeneca and Merck’s Lynparza sure isn’t. It picked up a blockbuster new approval late Wednesday and followed up the act by posting positive phase 3 data Thursday morning. U.S. regulators green-lighted the fast-growing PARP inhibitor in BRCA-mutated ovarian cancer patients who’ve responded partially or completely to an initial… Read More »